Evidence map›Paper›PMID 30477808›Full record

ArticleGynecologic oncology2019

The cost-effectiveness of opportunistic salpingectomy versus standard tubal ligation at the time of cesarean delivery for ovarian cancer risk reduction.

Akila Subramaniam, Brett D Einerson, Christina T Blanchard, Britt K Erickson, Jeff Szychowski, Charles A Leath, Joseph R Biggio, Warner K Huh

Registry-linked trialAbstract readComparative Study
In one paragraph

Article in Gynecologic oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06273683 (Comparison of Two Salpingectomy Techniques for Sterilization at the Time of Cesarean Delivery), which is not on this map. Cited by 10 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 3 pooled it
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06273683 recruitingnot on this mapstarted 2024, after this paper: background citation

Comparison of Two Salpingectomy Techniques for Sterilization at the Time of Cesarean Delivery

TypeobservationalSponsorInova Health Care ServicesRan2024 to 2027Enrolled900ConditionsPermanent Sterilization, Pregnancy RelatedArmsHand-held bipolar energy instrument, Traditional suture ligation
3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 3 syntheses or guidelines pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Akila SubramaniamUniversity of Alabama at Birmingham, Center for Women's Reproductive Health, Department of Obstetrics and Gynecology, Birmingham, AL, United States of America. Electronic address: asubramaniam@uabmc.edu.
Brett D EinersonUniversity of Utah, Division of Maternal-Fetal Medicine, Salt Lake City, UT, United States of America.
Christina T BlanchardUniversity of Alabama at Birmingham, Center for Women's Reproductive Health, Department of Obstetrics and Gynecology, Birmingham, AL, United States of America.
Britt K EricksonUniversity of Minnesota, Division of Gynecologic Oncology, Minneapolis, MN, United States of America.
Jeff SzychowskiUniversity of Alabama at Birmingham, Center for Women's Reproductive Health, Department of Obstetrics and Gynecology, Birmingham, AL, United States of America.
Charles A LeathUniversity of Alabama at Birmingham, Division of Gynecologic Oncology, Birmingham, AL, United States of America.
Joseph R BiggioOchsner Health System, New Orleans, LA, United States of America.
Warner K HuhUniversity of Alabama at Birmingham, Division of Gynecologic Oncology, Birmingham, AL, United States of America.
University of Alabama at Birmingham · USOchsner Health System · USUniversity of Minnesota · USUniversity of Utah · US

Funding

XRAY CRYSTALLOGRAPHYP30CA013148 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Omer Jamy · 1985 to 2026
$165.9M
Women's CancerP30CA077598 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Timothy C. Hallstrom · 1998 to 2026
$100.4M
NCTN Deep South Research ConsortiumU10CA180855 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BJORNSTI, MARY-ANN, FALKSON, CARLA I · 2014 to 2018
$2.6M
NCI NIH HHS P30 CA013148NCI NIH HHS P30 CA077598NCI NIH HHS U10 CA180855
6 · The paper itself

Abstract

objectivesOpportunistic salpingectomy is a cost-effective strategy recommended for ovarian cancer (OvCa) risk reduction at the time of gynecologic surgery in women who have completed childbearing. We aimed to evaluate the cost-effectiveness of opportunistic salpingectomy compared to standard tubal ligation (TL) during cesarean delivery. STUDY

designA cost-effectiveness analysis using decision modeling to compare opportunistic salpingectomy to TL at the time of cesarean using probabilities of procedure completion derived from a trial. Probability and cost inputs were derived from local data and the literature. The primary outcome was the incremental cost-effectiveness ratio (ICER) in 2017 U.S. dollars per quality-adjusted life year (QALY) at a cost-effectiveness threshold of $100,000/QALY. One- and two-way sensitivity analyses were performed for all variables. A probabilistic sensitivity analysis determined the proportion of simulations in which each strategy would be cost-effective.

resultsOpportunistic salpingectomy was cost-effective compared to TL with an ICER of $26,616 per QALY. In 10,000 women desiring sterilization with cesarean, opportunistic salpingectomy would result in 17 fewer OvCa diagnoses, 13 fewer OvCa deaths, and 25 fewer unintended pregnancies compared to TL - with an associated cost increase of $4.7 million. The model was sensitive only to OvCa risk reduction from salpingectomy and TL. Opportunistic salpingectomy was not cost-effective if its cost was >$3163.74 more than TL, if the risk-reduction of salpingectomy was <41%, or if the risk-reduction of TL was >46%. In probabilistic sensitivity analysis opportunistic salpingectomy was cost effective in 75% of simulations.

conclusionsIn women undergoing cesarean with sterilization, opportunistic salpingectomy is likely cost-effective and may be cost-saving in comparison to TL for OvCa risk reduction.

Indexed as

Cesarean SectionAdultCost-Benefit AnalysisFemaleHealth Care CostsHumansOvarian NeoplasmsPregnancyQuality-Adjusted Life YearsRiskSalpingectomySterilization, TubalCesarean deliveryCost-effectivenessOvarian cancerSalpingectomyTubal ligation

Identifiers

PMID30477808
PMCPMC6321779
OpenAlexW2900881841

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.